Related Experiment Video

Updated: Jun 4, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

The relation of age to the severity of Type I diabetes in children

Suliman H Al-Fifi1

  • 1College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.

Journal of Family & Community Medicine
|March 2, 2011
PubMed

Insights

Younger children with Type 1 diabetes (T1D) present with more severe symptoms, including diabetic ketoacidosis, and have longer hospital stays. Early diagnosis and referral by primary care are crucial for better outcomes in pediatric T1D.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Type 1 diabetes (T1D) is a chronic condition affecting children.
  • Early diagnosis and management are critical for preventing complications.

Purpose of the Study:

  • To investigate the relationship between age and the severity of Type 1 diabetes in children.
  • To compare T1D presentation in children aged 0-5 years versus those older than 5 years.

Main Methods:

  • Retrospective review of pediatric patients with T1D admitted between 2000 and 2006.
  • Analysis of patient demographics, symptom duration, diabetic ketoacidosis presence, and hospital stay.

Main Results:

  • 181 children with T1D were analyzed; 27.6% were 5 years or younger.
  • Younger children (≤5 years) had longer symptom duration, higher rates of diabetic ketoacidosis (31.4% vs 15.3%), and longer hospital stays.
  • Biochemical test results were significantly different in the younger age group.

Conclusions:

  • Younger children with T1D are more likely to present with delayed diagnosis and diabetic ketoacidosis.
  • Enhanced training for primary healthcare personnel is needed for earlier detection and referral of pediatric T1D cases.
Abstract

Keywords:
Type 1 diabetesbiochemicalchildrenlaboratoryseverity

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...